Lakewood-amedex Biotherapeutics Incの企業情報（従業員数・代表者名など）
最終更新日：2026年5月13日
特色
Lakewood-amedex Biotherapeutics Inc is a pharmaceutical company. The Company is focused on addressing unmet needs in the treatment of serious infectious diseases, improving patient outcomes, and significantly reducing the threat posed by antibiotic-resistant bacterial strains like MRSA, NDM-1, and many others. The Company is engaged in development of its Bisphosphocin class of antimicrobial agents. The Company is exploring additional local drug delivery applications, including complicated urinary tract infections (CAUTI) and pulmonary infections. The Company has a portfolio of compounds that are being profiled for indications such as infected diabetic foot ulcer, urinary tract infections, and pulmonary infections.
企業情報
| 英文社名 | Lakewood-amedex Biotherapeutics Inc |
|---|---|
| 本社所在地 | 8031 Cooper Creek Blvd., Unit 103 UNIVERSITY PARK, FL 34201 USA |
| 電話番号 | 941 225-2515 |
| 設立年月 | 2025年6月 |
| 代表者名 | Kelvin Cooper |
| 業種名 | 医療関連（Health Care） |
| 市場名 | --- |
| 従業員数 | --- |
| ウェブサイト | https://lakewoodamedex.com |
企業の強みが業績にどのように表れているか、業績情報よりご確認いただけます。
業績情報を見る
